Prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease
نویسندگان
چکیده
Postprint This is the accepted version of a paper published in Alimentary Pharmacology and Therapeutics. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease. Access to the published version may require subscription. Abstract Background: Faecal calprotectin, an established biomarker used to assess mucosal inflammation,
منابع مشابه
Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
Background: Inflammatory bowel disease (IBD) involves chronic inflammation of the digestive tract. In the past decades, fecal calprotectin has been proposed as a useful biomarker for the differential diagnosis between IBD patients and healthy controls. We designed this study to evaluate the diagnostic ability of fecal calprotectin (FC) and conventional inflammatory markers in IBD patients. M...
متن کاملFaecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
Inflammatory bowel disease (IBD) should be suspected in any patient presenting with chronic or recurrent abdominal pain and diarrhoea. Current guidelines suggest performing invasive endoscopy with histological sampling for further diagnosis. Measuring calprotectin, a neutrophilic protein, in faeces has been proposed as a surrogate marker of intestinal inflammation. Calprotectin values have been...
متن کاملFaecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
OBJECTIVE To evaluate whether including a test for faecal calprotectin, a sensitive marker of intestinal inflammation, in the investigation of suspected inflammatory bowel disease reduces the number of unnecessary endoscopic procedures. DESIGN Meta-analysis of diagnostic accuracy studies. DATA SOURCES Studies published in Medline and Embase up to October 2009. Interventions reviewed Measure...
متن کاملFaecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
The present study aimed to investigate faecal calprotectin as a diagnostic marker to differentiate between patients with inflammatory bowel disease (IBD) and those with irritable bowel syndrome (IBS). A total of 20 healthy control subjects, 26 patients with IBS and 58 patients with IBD, including 22 with ulcerative colitis (UC) and 36 with Crohn's disease (CD), were recruited for the present st...
متن کاملComment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”
We read with interest the article entitled “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systemic Review,” which brings forward evidence that serum and faecal biomarkers do not possess adequate operational characteristics to make them stand-alone treatment targets in inflammatory bowel disease (IBD) but should be considered as important adjunctive measures to clini...
متن کامل